AI-generated summary
The authors compared fractional Er:YAG laser alone with the same laser plus topical steroid in 22 patients with melasma, using each patient's two sides of the face. Both sides improved clinically and histologically, with the combined treatment reported as giving more significant improvement. The authors also note the combined therapy appeared more beneficial for Fitzpatrick skin type III than type IV.
- Participants
- 22
- Who or what was studied
- Patients with melasma (22 patients, split-face design)
- Limits stated in the abstract
- The abstract describes a small single-group split-face design with a follow-up of only 3 months after treatment sessions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Collagen. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.